Evanson Jeff - Insider Non-Derivative Transactions at Outlook Therapeutics, Inc. (OTLK) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Mar 7, 2024, Evanson Jeff's relationship to Outlook Therapeutics, Inc. (OTLK) is Officer (CHIEF COMMERCIAL OFFICER), and currently has 808,459 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OTLK insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Evanson Jeff - Insider Non-Derivative Transactions of OTLK Common Stock

Evanson Jeff - Insider Non-Derivative Transactions at OTLK

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Mar 8, 2024	P -- (Common Stock)	62484	0.42	808459
Jan 21, 2023	Sell -- (Common Stock)	267000	1.11	745975
Jan 20, 2023	Sell -- (Common Stock)	103255	1.22	1012975
Jan 19, 2023	Sell -- (Common Stock)	33738	1.25	1116230
Jan 18, 2023	Sell -- (Common Stock)	27162	1.31	1149968